Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence

The current classification of ductal carcinoma in situ (DCIS) is based on nuclear grade, architectural differentiation and the presence of necrosis that does not adequately predict the likelihood of recurrence after breast conserving therapy; therefore, there is a critical need to identify novel pre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Witkiewicz, Agnieszka K, Freydin, Boris, Chervoneva, Inna, Potoczek, Magdalena, Rizzo, Wendy, Rui, Hallgeir, Brody, Jonathan R, Schwartz, Gordon F, Lisanti, Michael P
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Landes Bioscience 2010
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3040854/
https://ncbi.nlm.nih.gov/pubmed/20574156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.10.4.12449
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak